Valuation Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX Other stock markets 13:12:46 2026-07-24 EDT			5-day change	1st Jan Change
479.94 ^USD	+1.45%		-1.27%	+5.76%

07-21	Morgan Stanley Downgrades Vertex Pharmaceuticals to Equalweight From Overweight, Adjusts PT to $15 From $19	MT
07-20	Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	55,834	74,127	104,849	103,707	115,026	120,073	-	-
Change	-	32.76%	41.44%	-1.09%	10.91%	4.39%	-	-
Enterprise Value (EV) ¹	48,309	63,349	93,630	97,591	108,418	106,330	101,461	96,432
Change	-	31.13%	47.8%	4.23%	11.09%	-1.93%	-4.58%	-4.96%
P/E	24.4x	22.5x	29.3x	-194x	29.6x	27x	23.8x	19.7x
PBR	5.53x	5.33x	5.96x	6.4x	6.17x	5.42x	4.49x	3.78x
PEG	-	0.5x	3.51x	2x	-0x	1.9x	1.8x	1x
Capitalization / Revenue	7.37x	8.3x	10.6x	9.41x	9.58x	9.2x	8.37x	7.47x
EV / Revenue	6.38x	7.09x	9.49x	8.86x	9.03x	8.15x	7.07x	6x
EV / EBITDA	10.8x	12.8x	20.6x	108x	19.8x	18.4x	15.3x	12.6x
EV / EBIT	11.1x	13.2x	21.4x	140x	20.6x	19.2x	16x	13x
EV / FCF	20.1x	16.1x	28.1x	-123x	33.9x	21.5x	20.8x	18.8x
FCF Yield	4.99%	6.2%	3.56%	-0.81%	2.95%	4.66%	4.8%	5.32%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	9.01	12.82	13.89	-2.08	15.32	17.54	19.9	24.01
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	7,574	8,931	9,869	11,020	12,001	13,046	14,347	16,084
EBITDA ¹	4,470	4,941	4,556	902.8	5,473	5,789	6,650	7,648
EBIT ¹	4,344	4,793	4,375	695.6	5,263	5,525	6,331	7,406
Net income ¹	2,342	3,322	3,620	-535.6	3,953	4,518	5,136	6,175
Net Debt ¹	-7,525	-10,778	-11,218	-6,116	-6,608	-13,743	-18,611	-23,641
Reference price ²	219.60	288.78	406.89	402.70	453.36	473.09	473.09	473.09
Nbr of stocks (in thousands)	254,252	256,691	257,683	257,529	253,719	253,805	-	-
Announcement Date	1/26/22	2/7/23	2/5/24	2/10/25	2/12/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	26.97x	8.15x	18.37x	-.--%	120B
ELI LILLY AND COMPANY	35.39x	12.58x	26.43x	0.57%	1,057B
JOHNSON & JOHNSON	27.79x	6.35x	17.58x	2.07%	624B
ABBVIE INC.	33.47x	7.59x	15.59x	2.68%	454B
ROCHE HOLDING AG	20.98x	4.63x	11.4x	2.86%	341B
NOVARTIS AG	21.62x	5.7x	13.97x	2.82%	297B
ASTRAZENECA PLC	21.08x	4.45x	12.3x	1.98%	262B
NOVO NORDISK A/S	14.13x	5.26x	10.83x	3.54%	215B
AMGEN INC.	24.37x	6.41x	11.32x	2.71%	201B
GILEAD SCIENCES, INC.	-47.14x	5.65x	31.2x	2.52%	162B
Average	17.86x	6.68x	16.90x	2.18%	373.4B
Weighted average by Cap.	24.79x	7.89x	18.52x	1.92%